List of Tables
    Table 1. HER-2 Targeted Drugs for Breast Cancer Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. HER-2 Targeted Drugs for Breast Cancer Market Trends
    Table 3. HER-2 Targeted Drugs for Breast Cancer Market Drivers
    Table 4. HER-2 Targeted Drugs for Breast Cancer Market Challenges
    Table 5. HER-2 Targeted Drugs for Breast Cancer Market Restraints
    Table 6. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States HER-2 Targeted Drugs for Breast Cancer Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States HER-2 Targeted Drugs for Breast Cancer Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top HER-2 Targeted Drugs for Breast Cancer Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global HER-2 Targeted Drugs for Breast Cancer Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global HER-2 Targeted Drugs for Breast Cancer Revenue Share by Player, 2017-2022
    Table 13. Global HER-2 Targeted Drugs for Breast Cancer Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global HER-2 Targeted Drugs for Breast Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HER-2 Targeted Drugs for Breast Cancer as of 2021)
    Table 15. Top Players of HER-2 Targeted Drugs for Breast Cancer in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into HER-2 Targeted Drugs for Breast Cancer Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top HER-2 Targeted Drugs for Breast Cancer Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States HER-2 Targeted Drugs for Breast Cancer Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States HER-2 Targeted Drugs for Breast Cancer Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global HER-2 Targeted Drugs for Breast Cancer Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America HER-2 Targeted Drugs for Breast Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific HER-2 Targeted Drugs for Breast Cancer Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe HER-2 Targeted Drugs for Breast Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa HER-2 Targeted Drugs for Breast Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa HER-2 Targeted Drugs for Breast Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Roche Company Details
    Table 31. Roche Business Overview
    Table 32. Roche HER-2 Targeted Drugs for Breast Cancer Product
    Table 33. Roche Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 34. Roche Recent Development
    Table 35. Chugai Pharmaceutical Company Details
    Table 36. Chugai Pharmaceutical Business Overview
    Table 37. Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Product
    Table 38. Chugai Pharmaceutical Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 39. Chugai Pharmaceutical Recent Development
    Table 40. GlaxoSmithKline Company Details
    Table 41. GlaxoSmithKline Business Overview
    Table 42. GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Product
    Table 43. GlaxoSmithKline Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 44. GlaxoSmithKline Recent Development
    Table 45. Novartis Company Details
    Table 46. Novartis Business Overview
    Table 47. Novartis HER-2 Targeted Drugs for Breast Cancer Product
    Table 48. Novartis Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 49. Novartis Recent Development
    Table 50. Pfizer Company Details
    Table 51. Pfizer Business Overview
    Table 52. Pfizer HER-2 Targeted Drugs for Breast Cancer Product
    Table 53. Pfizer Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 54. Pfizer Recent Development
    Table 55. CANbridge Company Details
    Table 56. CANbridge Business Overview
    Table 57. CANbridge HER-2 Targeted Drugs for Breast Cancer Product
    Table 58. CANbridge Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 59. CANbridge Recent Development
    Table 60. Puma Biotechnology Company Details
    Table 61. Puma Biotechnology Business Overview
    Table 62. Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Product
    Table 63. Puma Biotechnology Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 64. Puma Biotechnology Recent Development
    Table 65. Hengrui Medicine Company Details
    Table 66. Hengrui Medicine Business Overview
    Table 67. Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Product
    Table 68. Hengrui Medicine Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 69. Hengrui Medicine Recent Development
    Table 70. Beacon Pharmaceuticals Limited Company Details
    Table 71. Beacon Pharmaceuticals Limited Business Overview
    Table 72. Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Product
    Table 73. Beacon Pharmaceuticals Limited Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 74. Beacon Pharmaceuticals Limited Recent Development
    Table 75. Hetero Drugs  Company Details
    Table 76. Hetero Drugs  Business Overview
    Table 77. Hetero Drugs  HER-2 Targeted Drugs for Breast Cancer Product
    Table 78. Hetero Drugs  Revenue in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022) & (US$ Million)
    Table 79. Hetero Drugs  Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. HER-2 Targeted Drugs for Breast Cancer Product Picture
    Figure 2. Global HER-2 Targeted Drugs for Breast Cancer Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global HER-2 Targeted Drugs for Breast Cancer Market Size 2017-2028 (US$ Million)
    Figure 4. United States HER-2 Targeted Drugs for Breast Cancer Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States HER-2 Targeted Drugs for Breast Cancer Market Size 2017-2028 (US$ Million)
    Figure 6. United States HER-2 Targeted Drugs for Breast Cancer Market Share in Global 2017-2028
    Figure 7. HER-2 Targeted Drugs for Breast Cancer Report Years Considered
    Figure 8. Product Picture of Trastuzumab
    Figure 9. Product Picture of Pertuzumab
    Figure 10. Product Picture of Lapatinib
    Figure 11. Product Picture of Neratinib
    Figure 12. Product Picture of Trastuzumab Emtansine
    Figure 13. Product Picture of Pyrotinib
    Figure 14. Product Picture of Other
    Figure 15. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Type in 2022 & 2028
    Figure 16. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Type (2017-2028)
    Figure 18. United States HER-2 Targeted Drugs for Breast Cancer Market Share by Type in 2022 & 2028
    Figure 19. United States HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2017-2028) & (US$ Million)
    Figure 20. United States HER-2 Targeted Drugs for Breast Cancer Market Share by Type (2017-2028)
    Figure 21. Product Picture of Hospital
    Figure 22. Product Picture of Clinic
    Figure 23. Product Picture of Drug Center
    Figure 24. Product Picture of Other
    Figure 25. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Application in 2022 & 2028
    Figure 26. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Application (2017-2028)
    Figure 28. United States HER-2 Targeted Drugs for Breast Cancer Market Share by Application in 2022 & 2028
    Figure 29. United States HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2017-2028) & (US$ Million)
    Figure 30. United States HER-2 Targeted Drugs for Breast Cancer Market Share by Application (2017-2028)
    Figure 31. North America HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. U.S. HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Canada HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Europe HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. Germany HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. France HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. U.K. HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Italy HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Russia HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 41. China HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Japan HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. South Korea HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. India HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Australia HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Taiwan HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Indonesia HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Thailand HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Malaysia HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Philippines HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Mexico HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Brazil HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Argentina HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 56. Turkey HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. U.A.E HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Roche Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 60. Chugai Pharmaceutical Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 62. Novartis Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 63. Pfizer Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 64. CANbridge Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 65. Puma Biotechnology Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 66. Hengrui Medicine Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 67. Beacon Pharmaceuticals Limited Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 68. Hetero Drugs  Revenue Growth Rate in HER-2 Targeted Drugs for Breast Cancer Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed